These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8504988)

  • 1. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis.
    Mittal KR; Barwick KW
    Gynecol Oncol; 1993 May; 49(2):197-201. PubMed ID: 8504988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
    Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
    Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
    Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.
    Ali A; Black D; Soslow RA
    Int J Gynecol Pathol; 2007 Apr; 26(2):115-23. PubMed ID: 17413976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
    Quick CM; May T; Horowitz NS; Nucci MR
    Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma.
    Hanley KZ; Dustin SM; Stoler MH; Atkins KA
    Int J Gynecol Pathol; 2010 Sep; 29(5):445-51. PubMed ID: 20736770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial carcinoma in adenomyosis: assessment of myometrial invasion on T2-weighted spin-echo and gadolinium-enhanced T1-weighted images.
    Utsunomiya D; Notsute S; Hayashida Y; Lwakatare F; Katabuchi H; Okamura H; Awai K; Yamashita Y
    AJR Am J Roentgenol; 2004 Feb; 182(2):399-404. PubMed ID: 14736670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumorous lymph-vascular invasion, grade of histologic differentiation, and myometrial infiltration as prognostic factors of endometrial carcinoma.
    De Góis NM; Martins NV; Abrão FS; De Lima GR; Alves AC
    Rev Paul Med; 1993; 111(3):385-90. PubMed ID: 8108630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
    Srodon M; Klein WM; Kurman RJ
    Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.
    Jacques SM; Lawrence WD
    Gynecol Oncol; 1990 Jun; 37(3):401-7. PubMed ID: 2351325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of MR features in adenomyosis.
    Tamai K; Koyama T; Umeoka S; Saga T; Fujii S; Togashi K
    Best Pract Res Clin Obstet Gynaecol; 2006 Aug; 20(4):583-602. PubMed ID: 16564228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases.
    Nofech-Mozes S; Ghorab Z; Ismiil N; Ackerman I; Thomas G; Barbera L; Covens A; Khalifa MA
    Am J Clin Pathol; 2008 Jan; 129(1):110-4. PubMed ID: 18089496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of myometrial invasion in endometrial carcinoma.
    Kaku T; Tsuruchi N; Tsukamoto N; Hirakawa T; Kamura T; Nakano H
    Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
    Lininger RA; Ashfaq R; Albores-Saavedra J; Tavassoli FA
    Cancer; 1997 May; 79(10):1933-43. PubMed ID: 9149020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology and physiopathology of adenomyosis.
    Bergeron C; Amant F; Ferenczy A
    Best Pract Res Clin Obstet Gynaecol; 2006 Aug; 20(4):511-21. PubMed ID: 16563870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
    Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
    Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.